Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,607 | Dovepress* | 6,299+ | 1,398 | 7,697 | |
PubMed Central* | 2,308 | 490 | 2,798 | ||
Totals | 8,607 | 1,888 | 10,495 | ||
*Since 3 December 2019 |
View citations on PubMed and Google Scholar